Explore Kura Oncology stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for KURA.

Kura Oncology Stock Price, Quotes and Forecasts | NASDAQ:KURA | Benzinga

Kura Oncology

Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.

bz_pharma_briefs

Biotech

News

Health Care

Movers

Trading Ideas

General

KURA

Kura Oncology and Kyowa Kirin reported positive Phase 2 results for ziftomenib in AML and plan Phase 3 trials, with an NDA submission set for Q2 2025.

Kura Oncology Cancer Study Hits Primary Goal, Lays Out Plans For Phase 3 Studies

Baidu Photo by testing on Shutterstock

Earnings

Equities

Eurozone

Commodities

Markets

BIDU

CLCO

PYXS

QUBT

SNOW

Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results

oil-prices-5079975

Intraday Update

Crude Oil Gains 1%; Deere Posts Better-Than-Expected Earnings

Kura Oncology Inc

Kura Sushi Inc

Kura Sushi USA, Inc. - Class A Common Stock

Kura Sushi USA Inc

Kuraray Co Ltd

Press Releases

Kura Oncology to Participate in JMP Securities Hematology and Oncology Summit

Kura Oncology to Host Virtual Investor Event on December 9, 2024

Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting

Management

Kura Oncology Announces Senior Executive Promotions

Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Kura Oncology to Report Fourth Quarter and Full Year 2024 Financial Results

Kura Oncology to Participate in Three Upcoming Investor Conferences

Kura Oncology Reports Fourth Quarter and Full Year 2024 Financial Results

Financing

Akebia Therapeutics

AnaptysBio

Autolus Therapeutics plc - American Depositary Shares

Autolus Therapeutics

Bicara Therapeutics

Bicycle Therapeutics plc - American Depositary Shares

Bicycle Therapeutics

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics

Dianthus Therapeutics, Inc. - Common Stock

Dianthus Therapeutics

Immatics

KalVista Pharmaceuticals, Inc. - Common Stock

KalVista Pharma

MeiraGTx Hldgs

Opthea Limited - American Depositary Shares

Opthea

Organogenesis Holdings

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals

Precigen

Pharming Group N.V. - ADS, each representing 10 ordinary shares

Pharming

Relay Therapeutics

Sage Therapeutics

Sana Biotechnology

Sionna Therapeutics

Tourmaline Bio

Tyra Biosciences

Upstream Bio

Valneva

Verve Therapeutics

HC Wainwright & Co.

JMP Securities

Wedbush

Scotiabank

Learn About Cryptocurrency

acf/sidebar-related-posts

Learn about this leading blockchain platform that supports decentralized applications and smart contracts.

What is Ethereum?

Earning interest on your Ethereum is a great way to grow your cryptocurrency holdings. Find out how to earn interest on your Ethereum in 4 easy steps.

How to Earn Interest on Ethereum

Discover the 10 best cryptocurrencies to invest in for January 2025. Stay ahead in the crypto market with our expert insights and analysis! Learn more now!

10 Best Cryptocurrencies to Invest In for March 2025

10 Best Cryptocurrencies to Invest in for January 2025

Discover the best altcoins to invest in for high potential returns. Our top altcoin picks include Ethereum, Solana, Ripple, Dogecoin, Toncoin.

Top 10 Best Altcoins • Benzinga Crypto

10 Best Altcoins in November 2024

Top Cryptocurrency News

acf/news-feed

Future Finance Newsletter

acf/page-sidebar-placement

Cryptocurrency /Money Sidebar

Application error: a client-side exception has occurred (see the browser console for more information).